Physician
Farahmand, Shirin
Farahmand, Shirin was paid $247K by Medicaid between Jul 2018 and Aug 2023, across 78 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 14% of everything it billed.
33Billing provider infoFARAHMAND, SHIRIN
FULLERTON, CA 92635
FULLERTON, CA 92635
33aNPI1255384905assigned 05/17/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$247K
24GClaims135,776
24DCodes billed78
24AFirst – last monthJul 2018 – Aug 2023
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#77 of 222
Median peer was paid$42K
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38 | $2K | |
| 2019 | 123 | $6K | |
| 2020 | 59 | $3K | |
| 2021 | 36,990 | $67K | |
| 2022 | 54,490 | $91K | |
| 2023 | 44,076 | $78K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 14% | 620 | 611 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 18,767 | 11,493 | $25K |
| 80053 | Comprehensive metabolic panel | 9.2% | 12,389 | 9,121 | $23K |
| 83880 | 7.8% | 3,179 | 2,535 | $19K | |
| 84145 | 5.3% | 2,952 | 2,577 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.5% | 7,640 | 3,625 | $11K |
| 84484 | 3.9% | 4,503 | 3,573 | $10K | |
| 87040 | 3.3% | 2,579 | 2,143 | $8K | |
| 83605 | 2.9% | 4,011 | 3,007 | $7K | |
| 83735 | 2.8% | 5,306 | 1,846 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.7% | 2,282 | 2,123 | $7K |
| 82948 | 2.5% | 6,110 | 2,191 | $6K |
66 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 1,450 | $6K |
| 80074 | 2.2% | 670 | $5K | |
| 85027 | 1.6% | 3,646 | $4K | |
| 80061 | Lipid panel | 1.5% | 1,674 | $4K |
| 83690 | 1.5% | 3,047 | $4K | |
| 81001 | 1.4% | 6,157 | $3K | |
| 84100 | 1.2% | 3,483 | $3K | |
| 82803 | 1.2% | 896 | $3K | |
| 85730 | 1.2% | 2,412 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.2% | 1,714 | $3K |
| 85610 | 1.1% | 3,518 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 477 | $2K |
| 84703 | <1% | 2,442 | $2K | |
| 82728 | <1% | 829 | $2K | |
| 80076 | <1% | 1,309 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,080 | $2K |
| 84702 | <1% | 634 | $1K | |
| 85379 | <1% | 836 | $1K | |
| 87077 | <1% | 690 | $1K | |
| 82746 | <1% | 455 | $1K | |
| 87186 | <1% | 601 | $1K | |
| 86901 | <1% | 2,350 | $1K | |
| 86900 | <1% | 2,349 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 235 | $951.75 |
| 86780 | <1% | 411 | $943.92 | |
| 86850 | <1% | 1,714 | $936.86 | |
| 82570 | <1% | 951 | $869.52 | |
| 84439 | <1% | 539 | $845.88 | |
| 82607 | <1% | 823 | $837.45 | |
| 82550 | <1% | 650 | $821.92 | |
| 82140 | <1% | 305 | $787.08 | |
| 83550 | <1% | 565 | $775.56 | |
| 87081 | <1% | 683 | $715.68 | |
| 82043 | <1% | 680 | $683.40 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,568 | $675.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,269 | $653.21 |
| 83540 | <1% | 563 | $637.63 | |
| 82378 | <1% | 165 | $556.05 | |
| 87070 | <1% | 392 | $494.52 | |
| 87205 | <1% | 574 | $481.79 | |
| 84153 | <1% | 145 | $474.15 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,333 | $400.00 |
| 86880 | <1% | 394 | $383.02 | |
| 86140 | <1% | 400 | $368.67 | |
| 88304 | <1% | 13 | $341.32 | |
| 85652 | <1% | 710 | $336.07 | |
| 83615 | <1% | 306 | $329.43 | |
| 80047 | <1% | 435 | $268.42 | |
| 86300 | <1% | 70 | $236.80 | |
| 84550 | <1% | 252 | $199.20 | |
| 85007 | <1% | 297 | $173.88 | |
| 85380 | <1% | 115 | $130.34 | |
| 84156 | <1% | 191 | $125.46 | |
| 82962 | <1% | 414 | $111.92 | |
| 81003 | <1% | 228 | $99.54 | |
| 85046 | <1% | 106 | $97.52 | |
| 87075 | <1% | 46 | $60.48 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 40 | $56.00 |
| 80202 | <1% | 21 | $53.02 | |
| 85018 | <1% | 611 | $48.02 | |
| 85014 | <1% | 578 | $40.96 | |
| 82274 | <1% | 12 | $33.96 | |
| 84479 | <1% | 15 | $16.48 | |
| 81025 | <1% | 321 | $5.60 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 1,495 | $0.00 |
| 0240U | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.